Literature DB >> 34609399

Innovative nanotools for vascular drug delivery: the atherosclerosis case study.

Giulia De Negri Atanasio1, Pier Francesco Ferrari2, Roberta Campardelli3, Patrizia Perego3,4, Domenico Palombo2,4,5.   

Abstract

Cardiovascular diseases are the leading cause of mortality in the Western world. Among them, atherosclerosis represents one of the most common diseases in the modern society due to a common sedentary lifestyle, high-fat diet, and smoking. In the near future, a new approach could potentially improve the therapy of vascular pathologies, where to date the non-specific treatments present several limitations, such as poor biodistribution, quick elimination from the body, and undesired side-effects. In this field, nanotechnology has a great potential for the therapy and diagnosis of atherosclerosis with more and more recent and innovative publications. This review is a critical analysis of the results reported in the literature regarding the different and possible new approaches for the therapy and diagnosis of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34609399     DOI: 10.1039/d1tb01071a

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN: 2050-750X            Impact factor:   6.331


  1 in total

1.  Bevacizumab-Controlled Delivery from Polymeric Microparticle Systems as Interesting Tools for Pathologic Angiogenesis Diseases.

Authors:  Giulia De Negri Atanasio; Pier Francesco Ferrari; Roberta Campardelli; Giuseppe Firpo; Patrizia Perego; Domenico Palombo
Journal:  Polymers (Basel)       Date:  2022-06-26       Impact factor: 4.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.